Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00867854 · ClinicalTrials.gov registry record
Treatment De-Intensification and Residual HIV-1 in Youth
A clinical trial of HIV Infections and HIV-1, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 34
- Enrollment target
- 17
- Study locations
NCT00867854 is a study of HIV Infections and HIV-1 that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 34 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (92% lower). The trial reports 17 study locations across 10 states.
The verdict
NCT00867854, a study of HIV Infections and HIV-1, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
- 17
- Study locations
Study Summary
This laboratory-based sub-study of ATN 061 and ATN 071 will examine the effect of early treatment followed by treatment de-intensification to atazanavir/ritonavir (ATV/r) monotherapy on steady-state frequencies of replication-competent CD4+ T cell Human Immunodeficiency Virus (HIV)-1 reservoirs or cell-associated infectivity (CAI) and persistent low-level viremia (LLV), and their contribution to successful long-term control of HIV-1 replication among HIV-1 infected adolescents and young adults.
Conditions Studied
Interventions
- OTHER Blood draw
Study Locations (17)
Florida
- Children's Diagnostic and Teatment Center - Fort Lauderdale
- University of Miami School of Medicine - Miami
- University of South Florida College of Medicine - Tampa
California
- Children's Hospital of Los Angeles - Los Angeles
- University of California at San Francisco - San Francisco
District of Columbia
- Children's National Medical Center - Washington D.C.
- Howard University - IMPAACT Site - Washington D.C.
Illinois
- John Stroger Jr. Hospital of Cook County - Chicago
- Children's Memorial Hospital - Chicago
Maryland
- University of Maryland - Baltimore
- Johns Hopkins University - IMPAACT Site - Baltimore
New York
- Mount Sinai Medical Center - New York
- Montefiore Medical Center - The Bronx
Louisiana
- Tulane Medical Center - New Orleans
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00867854
The ClinicalTrials.gov registry entry for NCT00867854 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (92% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Blood draw is the first listed.
NCT00867854 reports 17 study locations spanning 10 distinct geographic areas - top geographies include Florida, California, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00867854 about?
NCT00867854 is a clinical study titled "Treatment De-Intensification and Residual HIV-1 in Youth". This laboratory-based sub-study of ATN 061 and ATN 071 will examine the effect of early treatment followed by treatment de-intensification to atazanavir/ritonavir (ATV/r) monotherapy on steady-state frequencies of replication-competent CD4+ T cell Human Immunodeficiency Virus (HIV)-1 reservoirs or c...
What is the current status of trial NCT00867854?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2009-02. Estimated completion is 2011-10.
What conditions does trial NCT00867854 study?
This clinical trial studies the following conditions: HIV Infections, HIV-1.
What interventions are being tested in trial NCT00867854?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT00867854?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00867854 being conducted?
This trial has 17 study locations across California, District of Columbia, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.